Senhwa Completes Enrollment of a Phase 2 Investigator Initiated Trial of Silmitasertib as Novel …

Headquartered in Taiwan, with an operational base in San Diego, California, Senhwa is well-positioned to oversee the development of its compounds.

Do you trust this headline?

Based on recent headline ratings, 88% of this readership currently trusts the local media, which has an average score of 84% regionally and is currently trending positive.

88%

Media Trust Score88%